Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Accounts Payable
$15,508 Mil (As of Sep. 2015)

GlaxoSmithKline PLC's quarterly accounts payable declined from Mar. 2015 ($16,873 Mil) to Jun. 2015 ($15,548 Mil) and declined from Jun. 2015 ($15,548 Mil) to Sep. 2015 ($15,508 Mil).

GlaxoSmithKline PLC's annual accounts payable increased from Dec. 2012 ($14,969 Mil) to Dec. 2013 ($15,715 Mil) but then declined from Dec. 2013 ($15,715 Mil) to Dec. 2014 ($13,529 Mil).


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Accts Payable 7,2619,81110,18613,34912,37914,04414,96915,71513,52915,886

GlaxoSmithKline PLC Quarterly Data

Accts Payable 14,29115,71514,40013,81414,37313,52916,87315,54815,50815,886
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership